Opus Genetics, Inc. (IRD)
4.80
-0.17
(-3.42%)
USD |
NASDAQ |
May 15, 16:00
4.805
0.00 (0.00%)
Pre-Market: 20:00
Opus Genetics Total Assets (Quarterly) : 66.79M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Keros Therapeutics, Inc. | 312.29M |
| Xilio Therapeutics, Inc. | 163.49M |
| ACADIA Pharmaceuticals, Inc. | 1.605B |
| Alnylam Pharmaceuticals, Inc. | 5.130B |
| Amgen, Inc. | 92.50B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 112.62M |
| Shareholders Equity (Quarterly) | -45.84M |
| Debt to Equity Ratio | -0.5658 |
| Current Ratio | 7.131 |
| Net Debt Paydown Yield | -0.44% |